What is the highest priority nursing intervention when admitting a pregnant woman who has experienced a bleeding episode in late pregnancy?

Cervidil (dinoprostone) is a medication used to ripen the cervix in preparation for labor induction in women who are at or near term.

Cervidil contains a synthetic form of prostaglandin E2, which helps to soften and thin the cervix, making it easier to dilate and efface during labor. The medication is usually administered vaginally, in the form of a small, flat, rectangular-shaped insert that is placed near the cervix.

The medication is released slowly over time, helping to ripen the cervix gradually.

Cervidil is not used to stimulate the amniotic membranes to rupture, enhance uteroplacental perfusion in an aging placenta, or increase amniotic fluid volume.

Infants of diabetic mothers (IDM) are at risk of hypoglycemia because they have been exposed to high levels of glucose in utero. The fetus responds to this high glucose level by producing high levels of insulin to regulate the glucose level. After delivery, the glucose supply from the mother is cut off and the infant's insulin levels remain high, leading to hypoglycemia.

Additionally, the infant's ability to produce glucose is immature and may not be sufficient to maintain normal blood glucose levels, especially if the infant is premature or small for gestational age. Therefore, IDM requires close monitoring of their blood glucose levels to prevent and treat hypoglycemia.